Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Tata Consumer Products to emerge as full-fledged FMCG company: N Chandrasekaran

Chandrasekaran said the COVID-19 pandemic impacted business in the last quarter of 2019-20 and the first quarter of the current fiscal.

July 06, 2020 / 04:58 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

N Chandrasekaran, chairman of the Tata Consumer Products Ltd said the company intends to establish itself as a fully-fledged FMCG company. The FMCG firm of the Tata Group was created following the merger of Tata Global Beverages and consumer business of Tata Chemicals.

The chairman said that the merger, which took effect from February, will provide a broader exposure to growth and opportunities in the FMCG space.

"TCPL will aim at emerging into a full-fledged FMCG firm and also scout for new opportunities in the international markets," Chandrasekaran told shareholders at the company's virtual annual general meeting.

He said the COVID-19 pandemic impacted business in the last quarter of 2019-20 and the first quarter of the current fiscal.

The company is expecting a slow recovery of the supply chain.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We expect the pandemic to continue in the near term and the company is positive about the current fiscal and beyond," Chandrasekaran said.

TCPL is looking at a vast portfolio of consumer products, he said, adding, demand for packaged foods is higher than usual as people have been stocking.

The company will strengthen distribution and marketing channels so that its products are available nationwide, he said. It will also bolster presence in the US, UK and Canada.

"We took a conscious call to broaden the focus to make it an integrated food and beverages company," Chandrasekaran said.

He said during the last financial year, Tata Starbucks opened 39 outlets, taking the total to 185 across the country.

"Owing to the pandemic, only 50 per cent of the outlets are open at the moment," Chandrasekaran said.

PTI
first published: Jul 6, 2020 04:35 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347